Fig. 4From: A novel microbial and hepatic biotransformation-integrated network pharmacology strategy explores the therapeutic mechanisms of bioactive herbal products in neurological diseases: the effects of Astragaloside IV on intracerebral hemorrhage as an exampleThe biotransformation-added targets of ASIV on ICH. A Twenty-seven additional genes overlap with ICH targets. B The PPI network of the 27 additional targets. C The distribution analysis of 27 additional targets suggests that the biotransformation products primarily act on microglia/macrophages. D The core subnetwork of 27 additional targets shows the central role of HRAS, PIK3R1, PTK2, CDC42, CSF1R, HGF, STAT1, and TNFBack to article page